Michelle Coffey is currently the Director of Global Regulatory Affairs for the Hospital Business Unit at Pfizer, a position held since 2022. They previously served as the Global Head of Regulatory Affairs & Pre-Clinical at Paradigm Biopharmaceuticals from 2019 to 2022, and have extensive experience in regulatory affairs at companies including Mesoblast Limited, Teva Pharmaceuticals, and Hospira. Michelle holds an MSc in Pharmaceutical Science from The University of Manchester and a BSc in Industrial Chemistry from the University of Limerick, alongside a Diploma in Chemical Analysis from the Institute of Technology, Tallaght.
This person is not in any teams
This person is not in any offices